IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel
SHANGHAI, NANJING, China and SAN FRANCISCO, May 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and...
MUNIK Receives DEKRA's First ISO/PAS 8800 Certificate for Automotive AI Safety Development Process
SHANGHAI, April 30, 2025 /PRNewswire/ -- MUNIK, a leading automotive safety technology firm, has been awarded the world's first ISO/PAS 8800 certification by DEKRA, Germany's largest independent testing and certification organization. This milestone...
EP Cube Receives Prestigious 2025 iF Design Award and Gold at the 2025 MUSE Design Awards
KITCHENER, ON, April 29, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that its residential energy storage system, EP Cube, has won the prestigious 2025 iF Design Award and Gold at the...
Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
HONG KONG, April 26, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical Products...
Weichai Wins SBR Manufacturing Award 2025 for Advancing Efficiency and Green Innovation
SINGAPORE, April 25, 2025 /PRNewswire/ -- World-leading engine manufacturer Weichai has received the 2025 Manufacturing Award at the Singapore Business Review (SBR) International Business Awards. The accolade recognizes the company's breakthroughs...
CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry
- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion - Positioned for global expansion in $750M spinal bone graft market SEOUL, South Korea, April 24, 2025 /PRNewswire/ -- CGBIO(CEO Hyun...
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
SUZHOU, China, April 16, 2025 /PRNewswire/ -- April 12, 2025, Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational...
Amcor receives 'AA' MSCI ESG rating, recognizing its commitment to sustainability
ZURICH, April 14, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has been recognized with an 'AA' rating by MSCI ESG Research for its strong sustainability performance....
SMU Receives S$3.5 Million Gift from Kwan Im Thong Hood Cho Temple to Advance Inter-Religious Studies and Support Students in Need
SINGAPORE, April 10, 2025 /PRNewswire/ -- Amidst evolving global religious dynamics, Singapore Management University (SMU) has announced the establishment of the Kwan Im Thong Hood Cho Temple Chair Professorship in Inter-Religious Studies &...
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine
YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly developed by GC Biopharma and the Korea Disease...